We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
-15.72%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$4.46B
AUM Growth
-$6B
Cap. Flow
-$4.51B
Cap. Flow %
-101.07%
Top 10 Hldgs %
21.21%
Holding
7,134
New
733
Increased
2,939
Reduced
2,324
Closed
739

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$411M
2
MSFT icon
Microsoft
MSFT
+$372M
3
AMZN icon
Amazon
AMZN
+$192M
4
TSLA icon
Tesla
TSLA
+$121M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$111M

Sector Composition

Rank Sector Weight
1 Technology 22.55%
2 Healthcare 10.82%
3 Consumer Discretionary 9.19%
4 Financials 8.34%
5 Communication Services 7.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BEST
4101
DELISTED
BEST Inc. American Depositary Shares, each representing twenty (20) Class A Ordinary Shares
BEST
$15K ﹤0.01%
+3,204
New +$22.5K
PLMJU
4102
DELISTED
Plum Acquisition Corp. III Unit
PLMJU
$15K ﹤0.01%
1,519
MMV
4103
DELISTED
MultiMetaVerse Holdings Limited Class A Ordinary Share
MMV
$15K ﹤0.01%
1,520
VLD
4104
DELISTED
Velo3D, Inc.
VLD
$15K ﹤0.01%
318
+266
+512% +$31.1K
AKLI
4105
DELISTED
Akili Inc
AKLI
$15K ﹤0.01%
1,566
+690
+79% +$6.81K
DMTK
4106
DELISTED
DermTech, Inc. Common Stock
DMTK
$15K ﹤0.01%
2,730
-1,045
-28% -$8.56K
TTOO
4107
DELISTED
T2 Biosystems, Inc
TTOO
$15K ﹤0.01%
18
+16
+800% +$23.7K
APACU
4108
DELISTED
StoneBridge Acquisition Corporation Unit
APACU
$15K ﹤0.01%
1,469
THRX
4109
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
$15K ﹤0.01%
2,663
+1,255
+89% +$10.4K
HLGN
4110
DELISTED
Heliogen, Inc.
HLGN
$15K ﹤0.01%
206
-207
-50% -$26.9K
IRNT
4111
DELISTED
IronNet, Inc.
IRNT
$15K ﹤0.01%
6,482
+3,896
+151% +$11K
GWII
4112
DELISTED
Good Works II Acquisition Corp. Common Stock
GWII
$15K ﹤0.01%
1,551
-98
-6% -$969
DTRTU
4113
DELISTED
DTRT Health Acquisition Corp. Unit
DTRTU
$15K ﹤0.01%
1,385
-1
-0.1% -$10
FOXWU
4114
DELISTED
FoxWayne Enterprises Acquisition Corp. Unit
FOXWU
$15K ﹤0.01%
1,447
PRTY
4115
DELISTED
Party City Holdco Inc.
PRTY
$15K ﹤0.01%
11,780
-156,294
-93% -$346K
SCLEU
4116
DELISTED
Broadscale Acquisition Corp. Units
SCLEU
$15K ﹤0.01%
1,565
+1
+0.1% +$10
PHAS
4117
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
$15K ﹤0.01%
25,203
+24,950
+9,862% +$23.9K
MUDS
4118
DELISTED
Mudrick Capital Acquisition Corporation II Class A Common Stock
MUDS
$15K ﹤0.01%
1,490
-169
-10% -$1.7K
CMAX
4119
DELISTED
CareMax, Inc. Class A Common Stock
CMAX
$15K ﹤0.01%
+141
New +$24.2K
THER
4120
DELISTED
THERATECHNOLOGIES INC COM
THER
$15K ﹤0.01%
6,456
+2,137
+49% +$4.96K
ACHR icon
4121
Archer Aviation
ACHR
$5.16B
$14K ﹤0.01%
4,582
+2,114
+86% +$8.51K
ACHV icon
4122
Achieve Life Sciences
ACHV
$755M
$14K ﹤0.01%
2,893
+1,735
+150% +$11.8K
AKBA icon
4123
Akebia Therapeutics
AKBA
$243M
$14K ﹤0.01%
39,433
-17,625
-31% -$7.39K
ASLE icon
4124
AerSale
ASLE
$275M
$14K ﹤0.01%
934
+383
+70% +$5.56K
AUBN icon
4125
Auburn National Bancorp
AUBN
$91.6M
$14K ﹤0.01%
505
+501
+12,525% +$15.2K

Similar funds

Tower Research Capital (TRC)'s Q2 2022 Portfolio in Review

As of Q2 2022, Tower Research Capital (TRC) held 7,134 positions worth $4.46B, down 57% from $10.5B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Tower Research Capital (TRC) withdrew a net $4.51B in Q2 2022, closing 739 positions and reducing 2,324 holdings. Its most notable exit was iShares MSCI USA Value Factor ETF, an estimated $13.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 31% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Russell 1000 Value ETF worth $23.4M.

  • Tower Research Capital (TRC)'s largest Q2 2022 buy was iShares Russell 1000 Value ETF: 161,690 shares worth $23.4M.
  • Tower Research Capital (TRC) added most to iShares Russell 2000 ETF in Q2 2022, an estimated $41.1M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2022 reduction was Apple, cutting an estimated $411M.
  • Tower Research Capital (TRC) fully exited iShares MSCI USA Value Factor ETF in Q2 2022, selling an estimated $13.8M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 21% of its $4.46B portfolio in Q2 2022.
  • Tower Research Capital (TRC) opened 733 new positions and closed 739 in Q2 2022.
  • Tower Research Capital (TRC)'s portfolio value fell 57% quarter-over-quarter to $4.46B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2022, filed 15 Aug 2022.